Morgan Stanley Bearish on RIMM Shares, Credit Suisse Sees Upside for Coach and Nike

Research In Motion Limited (NASDAQ:RIMM): Morgan Stanley’s checks indicate Asian supplier orders fall sharply and as a result the firm lowered Research in Motion’s Q4 and FY13 estimates. Shares are Equal Weight rated.

Coach Inc.(NYSE:COH): Credit Suisse said footwear vendors and retailers will likely have a much improved 2H 2012 sourcing position due to easing costs. The firm expects Coach (NYSE:COH), Nike (NYSE:NKE), and Polo Ralph Lauren (NYSE:RL) to be the biggest beneficiaries.

VIVUS Inc.(NASDAQ:VVUS): Jefferies thinks the FDA panel vote next Wednesday for VIVUS’s weight loss drug Qnexa is likely a close call, but the firm is leaning towards a slightly positive panel. However, Jefferies remains cautious on approval of the drug in April given the FDA’s cautious stance on teratogenicity and cardiovascular concerns. The firm keeps an Underperform rating on VIVUS with a $3 price target.

Masimo Corporation(NASDAQ:MASI): Brean Murray raised its price target following Q4 results. The firm cited strong execution, good guidance, and overall conviction of the fundamental outlook for its business. Shares are Buy rated.

Horizon Pharma Inc(NASDAQ:HZNP): JMP Securities believes that the early metrics for Horizon’s Duexis indicate that the drug could beat expectations. The firm reiterates a $16 target and Outperform rating on the stock.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at